The biotech revolution is upon us 📺 As the world grapples with aging populations and complex diseases, enzymes are emerging as the linchpins of innovation. At #Allozymes, we’re excited to be at the forefront of this golden age, harnessing the power of enzymes to create transformative solutions. Are you ready to unlock the potential of biology? #Biotechnology #Enzymes #Healthcare #Investment
Allozymes
Biotechnology Research
Singapore, Singapore 10,469 followers
Evolving Biology, Advancing Tomorrow
About us
Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.
- Website
-
https://www.allozymes.com/
External link for Allozymes
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Singapore, Singapore
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
79 Science Park Drive
06-05
Singapore, Singapore 118264, SG
Employees at Allozymes
Updates
-
"Celiac disease affects around one in a hundred people worldwide, and those that have the autoimmune disorder have no choice but to stick to a gluten-free diet forever—at the moment, doctors have no other way to treat the illness. Now, those seeking a treatment could get a boost: A new study from researchers at Stanford University and the Stanford Synchrotron Radiation Lightsource (SSRL) at the U.S. Department of Energy (DOE)'s SLAC National Accelerator Laboratory has revealed previously unseen details of a key enzyme behind the disease." "These insights can be used to make better drugs against this target." Optimistic #science news of the day ☺️ #Biotechnology #Enzymes #CeliacDisease
Researchers advance understanding of a key celiac enzyme
phys.org
-
We're excited to get innovating together with Syensqo 😎 #Biotechnology #Enzymes #Allozymes
Did you know Asia is Syensqo’s second-largest region, making up 35% of our sales? As Chief Asia Officer, I had the honor of welcoming the Executive Leadership Team and engaging with nearly 95% of our workforce, #customers, and #partners in the region, who are driving sustainable innovations forward. Here’s why we’re excited about Asia: We have unmatched teams with a winning mindset! From lab visits to town hall meetings, our teams of explorers displayed incredible energy and passion for #innovation. For example, in Singapore, our partnership with Allozymes is crafting cleaner bio-based skincare solutions. With our customer Hegen, we are redefining baby products using #Syensqo’s safest and high-purity materials. In Korea, together with 이화여자대학교, we nurture promising young women scientists. The celebration of our 10-year anniversary of our joint Research and Innovation Center in Seoul, was just one of my favorite highlights of this trip. In China, the Sipomer® PAM production line expansion in our Zhenjiang site, inaugurated with CEO Ilham Kadri, showcases our commitment to sustainable solutions for the coating industry and our joint lab with NIO underscores our leadership in the electric vehicle sector. Last but not least, in Japan, together with Rapidus Corporation, we are tackling global semiconductor shortages. With immense talent, a great innovation ecosystem and vast opportunities, Asia's growth potential for Syensqo is boundless. Stay tuned for more! #WeAreExplorers #AdvancingHumanity #strategy Ilham Kadri Marc Chollet Hervé Tiberghien Christopher Davis Mark Rollinger
-
+1
-
🚨 Panel Alert 🚨 Our CTO and co-founder Akbar Vahidi will speaking at IPOS International's IP Week: The Start-up IP Playbook: What Every Founder Should Know Akbar and the rest will offer invaluable insights and practical advice on how to avoid common pitfalls, attract investors, and scale effectively 💪 📅 Save the date: 27 August, 4pm – 5:30pm 📍 IP Week @ SG 2024, Panel 2A, at Marina Bay Sands Expo & Convention Centre #Biotechnology #IP #Scaling #Allozymes
-
Team dinner with a view 🏙️ #Singapore #TeamOuting #Biotechnology
-
It seems like there's a rush to the polls this year! 🗳️ 💨 Well, here's one we're curious about. Let us know what you think ⬇️ #Biotechnology #RocktheVote #Innovation
This content isn’t available here
Access this content and more in the LinkedIn app
-
Scientists at King's College London have made a breakthrough in replicating an enzyme that captures carbon dioxide from the atmosphere ⛅️ This is a major step forward in the fight against climate change 🌍 Read more in the comments below 👇 #Biotechnology #Enzymes #Research
-
We're hiring in Toulouse, France! 🇫🇷 Are you passionate about using science to solve global challenges? We're looking for brilliant minds to join our mission👇 Here, you'll have the opportunity to: -Develop robust biosolutions: Be part of a team creating innovative enzymes and bioprocesses that are revolutionizing sustainable manufacturing ♻️ -Make a real impact: Contribute to a healthier planet by tackling climate change through the power of biotechnology ⚡️ -Work with the best: Collaborate with a passionate and talented team who are redefining the future 👏 #Allozymes #Biotechnology #ClimateTech #Sustainability #Careers
-
Allozymes reposted this
Look at that beauty of a 150L bioreactor! Massive! Floor loading, weight and height goto be one reason Allozymes graduated from A*StartCentral Congrats!
We're excited to unveil our brand new 150 L bioreactor, one of the few of its kind in Singapore 🇸🇬 This powerhouse is part of one of our #MultiZyme program—a unique approach to help companies seamlessly scale-up their bioactive products for crucial steps like regulatory testing, or even early commercial launches. How it works 📚 After our enzyme engineering platform service, #SingZyme, optimizes your product at the molecular level, the 150 L bioreactor then takes center stage, allowing us to produce the product in a controlled environment. This is perfect for pilot-scale production 🚀 We specifically created the MultiZyme program as many leaders in the pharmaceutical, personal care, and chemicals industry now require a faster time-to-market and smoother path to success for their innovative #biosolutions ♻️ Contact us today to learn more about how #Allozymes can help you navigate your biosolutions journey📱 #Biotechnology #Sustainability
-
We're excited to unveil our brand new 150 L bioreactor, one of the few of its kind in Singapore 🇸🇬 This powerhouse is part of one of our #MultiZyme program—a unique approach to help companies seamlessly scale-up their bioactive products for crucial steps like regulatory testing, or even early commercial launches. How it works 📚 After our enzyme engineering platform service, #SingZyme, optimizes your product at the molecular level, the 150 L bioreactor then takes center stage, allowing us to produce the product in a controlled environment. This is perfect for pilot-scale production 🚀 We specifically created the MultiZyme program as many leaders in the pharmaceutical, personal care, and chemicals industry now require a faster time-to-market and smoother path to success for their innovative #biosolutions ♻️ Contact us today to learn more about how #Allozymes can help you navigate your biosolutions journey📱 #Biotechnology #Sustainability